The effects of anti-arthritic gold compounds on mycoplasma and leishmania.
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006051:Aurothioglucose / Q000494:pharmacology / Q000627:therapeutic use; D006224:Cricetinae; D006046:Gold / Q000494:pharmacology* / Q000627:therapeutic use; D006052:Gold Sodium Thiomalate / Q000494:pharmacology / Q000627:therapeutic use; D007896:Leishmaniasis / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009174:Mycoplasma / Q000187:drug effects*; D010720:Phosphines / Q000494:pharmacology / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D010720:Phosphines; D006052:Gold Sodium Thiomalate; D006051:Aurothioglucose; D006046:Gold